CCI
ANAC

Columbus Circle Investors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Columbus Circle Investors’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-197,790
Closed -$22.3M – 342
2015
Q4 		$22.3M Buy
+197,790
New +$21.8M 0.18% 126
2015
Q1 		– Sell
-24,873
Closed -$802K – 360
2014
Q4 		$802K Buy
+24,873
New +$747K 0.01% 267
2013
Q4 		– Sell
-87,360
Closed -$928K – 388
2013
Q3 		$928K Sell
87,360
-436,955
-83% -$3.82M 0.01% 277
2013
Q2 		$2.93M Buy
+524,315
New +$3.17M 0.02% 248

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Columbus Circle Investors's ANAC Position: Q1 2016 in Review

Columbus Circle Investors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q1 2016, closing a stake of 197,790 shares — an estimated $22.3M sold.

Columbus Circle Investors first reported a position in ANAC in Q2 2013 and held it in 4 quarters. The position peaked at $22.3M in Q4 2015. 199 funds tracked by Wall St. Rank hold ANAC as of Q1 2016.

  • Columbus Circle Investors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q1 2016 after selling out during the quarter.
  • Columbus Circle Investors sold 197,790 ANACOR PHARMACEUTICALS INC COM shares in Q1 2016, an estimated $22.3M.
  • Columbus Circle Investors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 4 quarters.
  • Columbus Circle Investors's ANACOR PHARMACEUTICALS INC COM position peaked at $22.3M in Q4 2015.
  • 199 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q1 2016.

Based on Columbus Circle Investors's 13F filing for Q1 2016, filed 3 May 2016.